Iga Swiatek, the women's world No. 2 tennis player, has received a one-month doping ban after testing positive for trimetazidine, a substance primarily used for heart medication.
The International Tennis Integrity Agency ruled that Swiatek's level of fault was at the lowest end for 'No Significant Fault or Negligence,' indicating her positive test was not intentional.
After testing positive for a trace concentration of TMZ on August 12, Swiatek's provisional suspension was not publicly disclosed following a successful appeal against it.
The presence of trimetazidine in Swiatek's medications was confirmed to be from a melatonin supplement, which is available without a prescription in Poland and some EU countries.
Collection
[
|
...
]